Tandem Diabetes Care Inc. logo

Tandem Diabetes Care Inc.

TNDM | NASDAQ
Chart Builder DCF Calculator
$17.62
+$0.75 (+4.45%)
At close: Sep 21, 2026, 4:00 PM ET
$17.86
+$0.24 (+1.36%)
Pre-market: Sep 22, 2026, 8:30 AM ET

Market Data

Market Cap
$1.21B
Enterprise Value
$1.49B
Beta
1.56
Average Volume
2.27M
Shares Outstanding (Diluted)
68.4M
Shares Change YoY
2.01%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US8753722037

Price Performance

Price Change 1M
-21.3%
Price Change 3M
22.3%
Price Change 6M
-27.4%
Price Change YTD
-18.2%
Price Change 1Y
34.9%
Price Change 3Y
-14.4%
Price Change 5Y
-85.8%
1M CAGR (ann.)
-21.3%
1Y CAGR (ann.)
33.1%
5Y CAGR (ann.)
-31.9%
All-Time CAGR
-17.0%

Valuation

PE Ratio
-18.95
Forward PE
110.98
PEG Ratio
-0.18
Forward PEG
0.16
PS Ratio
1.16
Forward PS
1.00
PB Ratio
9.26
P/FCF Ratio
-55.31
P/Adj. FCF Ratio
-10.96
P/OCF Ratio
-220.25
EV/Sales
1.43
EV/EBIT
-28.25
EV/EBITDA
-49.18
EV/FCF
-68.28
Earnings Yield
-5.3%
FCF Yield
-1.8%
Adj. FCF Yield
-9.1%

Financial Health

Net Debt
$283.26M
Total Debt
$739.25M
Cash & Short-Term Investments
$456M
Total Assets
$1.15B
Current Ratio
3.18
Quick Ratio
2.65
Debt / Equity Ratio
5.67
Debt / EBITDA
-24.39
Debt / FCF
-33.86
OCF / Debt
0.01
Interest Coverage
-5.23
Altman Z-Score
0.46
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
56.0%
Operating Profit Margin
-4.1%
EBITDA Margin
-2.9%
Net Profit Margin
-6.1%
FCF Margin
-2.1%
Adj. FCF Margin
-10.6%
SBC / Revenue
7.0%
SBC Impact (per share)
-404.5%

Returns

Return on Assets
-5.5%
Return on Equity
-46.0%
Return on Invested Capital
-4.7%
Return on Capital Employed
-4.8%
Return on Tangible Assets
-5.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
9.6%
Revenue CAGR 5Y
11.5%
Revenue CAGR 10Y
28.1%
EPS CAGR 3Y
28.5%
EPS CAGR 5Y
-5.4%
EPS CAGR 10Y
32.8%
FCF CAGR 3Y
67.8%
FCF CAGR 5Y
-79.2%
FCF CAGR 10Y
15.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
39
EPS Growth Next 3Y
81.0%
Revenue Growth Next 3Y
13.1%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.26
EPS Growth Est (next Q)
-16.1%
Revenue Est (next Q)
$266.06M
Revenue Growth Est (next Q)
6.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$30.17
Price Target Upside
71.2%

Cash Flow

Operating Cash Flow
$5.53M
Free Cash Flow
$-21.83M
Adj. Free Cash Flow
$-110.14M
FCF Per Share
-$0.39
OCF Per Share
-$0.08
OCF/S Ratio
-0.5%

Income Statement

Revenue
$1.04B
Gross Profit
$583.32M
Operating Income
$-43M
EBITDA
$-30.31M
Net Income
$-63.32M
EPS (Diluted)
-$0.93
Revenue / Employee
$416.57K
Profit / Employee
$-25.33K
Employees
2,500

© 2026 bestshares.com. All rights reserved.